rs919198
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_001165963.4(SCN1A):c.4582-254G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0227 in 151,748 control chromosomes in the GnomAD database, including 183 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.023 ( 183 hom., cov: 32)
Consequence
SCN1A
NM_001165963.4 intron
NM_001165963.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.60
Publications
1 publications found
Genes affected
SCN1A (HGNC:10585): (sodium voltage-gated channel alpha subunit 1) Voltage-dependent sodium channels are heteromeric complexes that regulate sodium exchange between intracellular and extracellular spaces and are essential for the generation and propagation of action potentials in muscle cells and neurons. Each sodium channel is composed of a large pore-forming, glycosylated alpha subunit and two smaller beta subunits. This gene encodes a sodium channel alpha subunit, which has four homologous domains, each of which contains six transmembrane regions. Allelic variants of this gene are associated with generalized epilepsy with febrile seizures and epileptic encephalopathy. Alternative splicing results in multiple transcript variants. The RefSeq Project has decided to create four representative RefSeq records. Three of the transcript variants are supported by experimental evidence and the fourth contains alternate 5' untranslated exons, the exact combination of which have not been experimentally confirmed for the full-length transcript. [provided by RefSeq, Oct 2015]
SCN1A-AS1 (HGNC:54069): (SCN1A and SCN9A antisense RNA 1)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 2-165994670-C-T is Benign according to our data. Variant chr2-165994670-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 1207293.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.123 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SCN1A | ENST00000674923.1 | c.4582-254G>A | intron_variant | Intron 27 of 28 | NM_001165963.4 | ENSP00000501589.1 | ||||
| SCN1A | ENST00000303395.9 | c.4582-254G>A | intron_variant | Intron 26 of 27 | 5 | ENSP00000303540.4 | ||||
| SCN1A | ENST00000375405.7 | c.4549-254G>A | intron_variant | Intron 24 of 25 | 5 | ENSP00000364554.3 | ||||
| SCN1A | ENST00000409050.2 | c.4498-254G>A | intron_variant | Intron 26 of 27 | 5 | ENSP00000386312.1 |
Frequencies
GnomAD3 genomes AF: 0.0227 AC: 3440AN: 151630Hom.: 181 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
3440
AN:
151630
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0227 AC: 3448AN: 151748Hom.: 183 Cov.: 32 AF XY: 0.0254 AC XY: 1885AN XY: 74154 show subpopulations
GnomAD4 genome
AF:
AC:
3448
AN:
151748
Hom.:
Cov.:
32
AF XY:
AC XY:
1885
AN XY:
74154
show subpopulations
African (AFR)
AF:
AC:
164
AN:
41452
American (AMR)
AF:
AC:
1942
AN:
15206
Ashkenazi Jewish (ASJ)
AF:
AC:
46
AN:
3466
East Asian (EAS)
AF:
AC:
478
AN:
5124
South Asian (SAS)
AF:
AC:
34
AN:
4814
European-Finnish (FIN)
AF:
AC:
267
AN:
10582
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
475
AN:
67794
Other (OTH)
AF:
AC:
42
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
161
322
483
644
805
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
149
AN:
3464
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Aug 10, 2019
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.